Australian patients with chronic pain, inflammatory conditions, or tissue injuries that have not improved with standard treatments may benefit from mesenchymal stem cell therapy. The TGA classifies most MSC protocols as biological medicines requiring ARTG listing, severely restricting domestic availability. Our Chiang Mai clinic offers quality-controlled stem cell therapy approximately twelve hours from major Australian cities, with detailed treatment records provided for your Australian GP.
Stem cell therapy at Longevity Thailand uses mesenchymal stem cells (MSCs) to promote tissue repair, reduce systemic inflammation, and support regeneration. Protocols are individually designed based on your medical assessment, diagnostic imaging, and treatment goals. Visit our full Stem Cell Therapy page for detailed information on the science and process.
Australian patients value the quality-controlled MSC protocols, the structured clinical governance, and the significant cost difference compared to the limited domestic options available. Each stem cell programme is individually designed based on diagnostic assessment and treatment goals rather than a one-size-fits-all approach. English-speaking clinical staff ensure that patients fully understand the treatment process, expected outcomes, and follow-up requirements. Comprehensive treatment records are provided for your Australian GP or physiotherapist to support ongoing care.
Yes. Thailand has an established regulatory framework that permits stem cell therapy under proper medical supervision and quality standards.
Typically five to seven days in Chiang Mai, including assessment, treatment, and initial monitoring.
Yes. Many Australian patients combine stem cell therapy with anti-ageing, exosome, or musculoskeletal protocols during a single visit.
Structured video consultations are scheduled at regular intervals. Repeat blood work can be completed at any Australian pathology service, with results reviewed by our clinical team.
Stem cell therapy in Thailand is significantly more affordable than comparable options in Australia, where the limited private providers charge premium rates.
Yes. Comprehensive treatment summaries are provided for your local physician, including clinical notes, imaging, and follow-up recommendations.
The TGA classifies stem cell therapies as biological medicines requiring ARTG listing before they can be offered commercially. Most advanced mesenchymal stem cell protocols are not ARTG-listed, severely limiting their availability in Australian clinics.
A very limited number of private clinics in Australia offer some stem cell treatments under the TGA's exemption framework, but the range of protocols is narrow and costs are substantially higher than equivalent treatments in Thailand.
Yes. We provide detailed treatment summaries and can liaise directly with your GP for coordinated follow-up care. Many Australian GPs welcome this collaborative approach.